Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
989
datasets available to search
ShareScore release 0.9.0
Dataset results
989 results for “myelodysplastic syndrome”
Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblasti
ClinicalTrials.gov study NCT00860574. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cephalon Decitabine, Arsenic Trioxide and Ascorbic Acid for Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00621023. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Azacitidine and Etanercept in Treating Patients With Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00118287. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Decitabine and Clofarabine in Higher Risk Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT00903760. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Idarubicin, Cytarabine, and Pravastatin Sodium in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes
ClinicalTrials.gov study NCT01831232. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Arsenic Trioxide and Gemtuzumab Ozogamicin in Treating Patients With Advanced Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00274781. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Low-Dose Decitabine in Myelodysplastic Syndrome Post Azacytidine Failure
ClinicalTrials.gov study NCT00113321. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Idarubicin, Cytarabine, and Tipifarnib in Treating Patients With Newly Diagnosed Myelodysplastic Syndromes or Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00096122. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Vismodegib in Patients With Relapsed/Refractory Acute Myelogenous Leukemia and Relapsed Refractory High-Risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT01880437. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Trial of Decitabine in Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00760084. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Using the Anticancer Drug Olaparib to Treat Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome With an Isocitrate Dehydrogenase (IDH) Mutation
ClinicalTrials.gov study NCT03953898. IPD Sharing: YES. Countries: 1. Publications: 0.
Azacitidine and Lintuzumab in Treating Patients With Previously Untreated Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00997243. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pevonedistat, Azacitidine, Fludarabine Phosphate, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT03813147. IPD Sharing: YES. Countries: 1. Publications: 0.
A Dose Range Finding Study of Lenalidomide in Non-5q Chromosome Deletion in Low and Intermediate Risk Myelodysplastic Syndrome (MDS) Patients
ClinicalTrials.gov study NCT00699842. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Oral Dasatinib in Subjects With Myelodysplastic Syndrome (MDS) and Excess Marrow Blasts
ClinicalTrials.gov study NCT00624585. IPD Sharing: Not stated. Countries: 1. Publications: 0.
AG-013736 (Axitinib) In Patients With Poor Prognosis Acute Myeloid Leukemia (AML) Or Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00071006. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Sunitinib in Treating Patients With Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
ClinicalTrials.gov study NCT00451048. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Hypomethylating Properties of Freeze-dried Black Raspberries (BRB) in Patients With Myelodysplastic Syndrome or Myelodysplastic Syndrome/Myeloproliferative Neoplasm (MDS/MPN)
ClinicalTrials.gov study NCT03140280. IPD Sharing: NO. Countries: 1. Publications: 0.
Low-dose Oral Clofarabine for the Treatment of IPSS INT-1, INT-2 or HIGH Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia
ClinicalTrials.gov study NCT00708721. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenalidomide and Prednisone in Low and Int-1 Myelodysplastic Syndrome (MDS) Non 5q MDS
ClinicalTrials.gov study NCT01133275. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.